re: + updates + 23 Dec, 2004:
US FDA Grants Approval For Aridol Phase III Trial:
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=354608
18 Jan 2005: Applies for Regulatory Approval to market Aridol
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=356321
9 Febr: Pharmaxis to Commence UK Trial in Cystic Fibrosis
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=358485
23 Febr: US FDA Grants Bronchitol Orhpan Drug Status
http://stocknessmonster.com
2 March: Expands senior management team.
http://stocknessmonster.com/news-item?S=PXS&E=ASX&N=361578
Share price: $1.30
+ data and comment +, page-18
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.001(3.03%) |
Mkt cap ! $41.29M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $62.56K | 1.882M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 219277 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |